- Home
- STTK vs NISN Comparison
STTK vs NISN Comparison
Compare STTK & NISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- NISN
- Stock Information
- Founded
- STTK 2016
- NISN 2005
- Country
- STTK United States
- NISN China
- Employees
- STTK N/A
- NISN N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- NISN Metal Fabrications
- Sector
- STTK Health Care
- NISN Industrials
- Exchange
- STTK Nasdaq
- NISN Nasdaq
- Market Cap
- STTK 54.4M
- NISN 46.0M
- IPO Year
- STTK 2020
- NISN 2016
- Fundamental
- Price
- STTK $1.16
- NISN $5.28
- Analyst Decision
- STTK Hold
- NISN
- Analyst Count
- STTK 3
- NISN 0
- Target Price
- STTK $2.00
- NISN N/A
- AVG Volume (30 Days)
- STTK 332.9K
- NISN 131.3K
- Earning Date
- STTK 11-14-2024
- NISN 10-15-2024
- Dividend Yield
- STTK N/A
- NISN N/A
- EPS Growth
- STTK N/A
- NISN 12.54
- EPS
- STTK N/A
- NISN 4.19
- Revenue
- STTK $6,435,000.00
- NISN $452,263,984.00
- Revenue This Year
- STTK $313.04
- NISN N/A
- Revenue Next Year
- STTK N/A
- NISN N/A
- P/E Ratio
- STTK N/A
- NISN $1.30
- Revenue Growth
- STTK 382.75
- NISN 86.06
- 52 Week Low
- STTK $0.94
- NISN $3.14
- 52 Week High
- STTK $11.76
- NISN $22.55
- Technical
- Relative Strength Index (RSI)
- STTK 44.02
- NISN 30.48
- Support Level
- STTK $1.07
- NISN $5.14
- Resistance Level
- STTK $1.38
- NISN $6.11
- Average True Range (ATR)
- STTK 0.12
- NISN 0.69
- MACD
- STTK 0.01
- NISN -0.02
- Stochastic Oscillator
- STTK 27.88
- NISN 7.16
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About NISN NiSun International Enterprise Development Group Co. Ltd.
NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.